November 16, 2022

Paxlovid Reduces Risk of “Long COVID” After SARS-COV-2 Infection

With millions of people who recovered from COVID-19 having persistent conditions, called “long COVID,” a new study that involved over 56,000 U.S. veterans could be a game-changer. It found that the antiviral combination medication, Paxlovid, given in the first 5 days of infection decreases the risk of those longer term symptoms by 25%. Read more.


After Flu Shots, RA Patients Might Be Able to Resume Methotrexate Sooner

Methotrexate significantly decreases the response to vaccines for influenza and other viruses. That is why patients, such as those with rheumatoid arthritis (RA), are often advised to hold off on methotrexate treatment for 2 weeks after a flu shot. Find out why a new Korean study advises that 1 week of waiting after the flu shot should suffice.

Low-Dose Aspirin Increases Risk of Falls in Older Adults

Daily low-dose aspirin is used by many older adults for cardiovascular protection to reduce fractures and for other reasons. That is why a new substudy conducted in Australia is so consequential. It finds that low-dose aspirin used to reduce the risk of fractures also appears to increase the risk of serious falls. Learn more about the results of this study.


Pharmacist Video Series: Oral Liquid Methotrexate

In this latest Pharmacist Recommendation Series, U.S. Pharmacist Editor-in-Chief Robert Davidson interviews compounding/specialty pharmacist Amanda Ye, PharmD, RPh, who discusses the only FDA-approved oral liquid methotrexate option for pharmacists. Click here to view video.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Advertisement Advertisement